Prospects for reprogramming the immune system in multiple sclerosis

Prospects for reprogramming the immune system in multiple sclerosis

Библиографические подробности
Главный автор:	Waldmann, H
Формат:	Conference item
Опубликовано:	2007

Схожие документы

Reprogramming the immune system.
по: Waldmann, H
Опубликовано: (2008)

Reprogramming the immune system.
по: Waldmann, H
Опубликовано: (2002)

REPROGRAMMING THE IMMUNE-SYSTEM
по: Waldmann, H, и др.
Опубликовано: (1993)

Reprogramming the immune system using antibodies.
по: Graca, L, и др.
Опубликовано: (2006)

Reprogramming the immune system for tolerance with monoclonal antibodies.
по: Cobbold, S, и др.
Опубликовано: (1990)

Reprogramming the immune system towards regulation
по: Waldmann, H, и др.
Опубликовано: (2010)

Reprogramming the immune system: co-receptor blockade as a paradigm for harnessing tolerance mechanisms.
по: Waldmann, H, и др.
Опубликовано: (2008)

Astrocytes Undergo Metabolic Reprogramming in the Multiple Sclerosis Animal Model
по: Sofia Pereira das Neves, и др.
Опубликовано: (2023-10-01)

Reprogramming the immune system for peripheral tolerance with CD4 and CD8 monoclonal antibodies.
по: Cobbold, S, и др.
Опубликовано: (1992)

Reprogramming the immune system: a possible therapeutic approach to established autoimmune disease.
по: Waldmann, H, и др.
Опубликовано: (1993)

Effect of puberty on the immune system: Relevance to multiple sclerosis
по: Carmen C. Ucciferri, и др.
Опубликовано: (2022-12-01)

Immune-mediated genesis of multiple sclerosis
по: Salvatore Cavallo, MD, Specialist in Medical Genetics
Опубликовано: (2020-01-01)

Similarities in the Metabolic Reprogramming of Immune System and Endothelium
по: Chu-Yik Tang, и др.
Опубликовано: (2017-07-01)

THE INVERSION OF HOMEOSTATIC PROPERTIES OF THE IMMUNE SYSTEM IN PATIENTS WITH MULTIPLE SCLEROSIS
по: I. I. Andreevа, и др.
Опубликовано: (2016-06-01)

CAMPATH-IH in multiple sclerosis.
по: Moreau, T, и др.
Опубликовано: (1996)

Prospects of siponimod in secondary progressive multiple sclerosis
по: Marisa McGinley, и др.
Опубликовано: (2018-07-01)

Metabolic Reprogramming Induces Immune Cell Dysfunction in the Tumor Microenvironment of Multiple Myeloma
по: Shaojie Wu, и др.
Опубликовано: (2021-01-01)

Role of innate immune cells in multiple sclerosis
по: Carolina Prado, и др.
Опубликовано: (2025-02-01)

The Adaptive Immune System in Multiple Sclerosis: An Estrogen-Mediated Point of View
по: Alessandro Maglione, и др.
Опубликовано: (2019-10-01)

Prospects for the use of curcumin as an additional treatment for multiple sclerosis
по: V. S. Rogovskii, и др.
Опубликовано: (2023-08-01)

CELLULAR IMMUNITY PARAMETERS IN PATIENTS WITH REMITTING MULTIPLE SCLEROSIS
по: I. P. Ivanova, и др.
Опубликовано: (2021-10-01)

EBV-specific T-cell immunity: relevance for multiple sclerosis
по: Malina Behrens, и др.
Опубликовано: (2024-12-01)

Initial Immunopathogenesis of Multiple Sclerosis: Innate Immune Response
по: Norma Y. Hernández-Pedro, и др.
Опубликовано: (2013-01-01)

Acetate correlates with disability and immune response in multiple sclerosis
по: Silvia Pérez-Pérez, и др.
Опубликовано: (2020-11-01)

Neuro-immune crosstalk in depressive symptoms of multiple sclerosis
по: Chao Wang, и др.
Опубликовано: (2023-02-01)

CD8+ T cells as immune regulators of multiple sclerosis
по: Sushmita eSinha, и др.
Опубликовано: (2015-12-01)

Cerebrospinal fluid cells immune landscape in multiple sclerosis
по: Zijian Li, и др.
Опубликовано: (2021-03-01)

Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis.
по: Moreau, T, и др.
Опубликовано: (1996)

Immunotherapy of Cancer: Reprogramming Tumor-Immune Crosstalk
по: Kyle K. Payne, и др.
Опубликовано: (2012-01-01)

Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis.
по: Cox, A, и др.
Опубликовано: (2005)

Understanding and Modulating Immunity With Cell Reprogramming
по: Cristiana F. Pires, и др.
Опубликовано: (2019-12-01)

The cancer metabolic reprogramming and immune response
по: Longzheng Xia, и др.
Опубликовано: (2021-02-01)

Interferon gene therapy reprograms the leukemia microenvironment inducing protective immunity to multiple tumor antigens
по: Giulia Escobar, и др.
Опубликовано: (2018-07-01)

Prospects of laboratory risk evaluation of multiple sclerosis relapse and progressing
по: I. V. Smagina, и др.
Опубликовано: (2010-08-01)

Teriflunomide in the treatment of multiple sclerosis: current evidence and future prospects
по: Jiwon Oh, и др.
Опубликовано: (2014-09-01)

Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica.
по: Jarius, S, и др.
Опубликовано: (2008)

Lipid Metabolism Reprogramming of Immune Cells in Acne: An Update
по: Wu S, и др.
Опубликовано: (2023-09-01)

Role of Peripheral Immune Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
по: Sarah Dhaiban, и др.
Опубликовано: (2021-02-01)

Mitochondrial and metabolic dysfunction of peripheral immune cells in multiple sclerosis
по: Peng-Fei Wang, и др.
Опубликовано: (2024-01-01)

Berberine: A natural modulator of immune cells in multiple sclerosis
по: Esmaeil Yazdanpanah, и др.
Опубликовано: (2024-03-01)